| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $166.2M | -13.1% |
| Gross Profit | $71.0M | +3.2% |
| R&D Expense | $19.8M | -3.9% |
| SG&A Expense | $20.8M | +20.4% |
| Operating Income | $4.3M | +151.7% |
| Pre-tax Income | $1.3M | +109.4% |
| Income Tax | $44K | -93.6% |
| Net Income | $838K | -81.7% |
| EPS (Basic) | -$0.18 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.9M | -37.2% |
| Accounts Receivable | $25.1M | +81.7% |
| Inventory | $7.7M | -43.1% |
| Current Assets | $64.1M | -12.1% |
| Total Assets | $93.8M | -6.2% |
| Current Liabilities | $48.4M | -23.7% |
| Total Liabilities | $97.9M | -13.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.2M | -78.5% |
| Capital Expenditures | $661K | +561.0% |
| Investing Cash Flow | -$8.6M | -119.9% |
| Financing Cash Flow | -$13.4M | +65.4% |
| Free Cash Flow | $6.5M | -80.4% |
| -280.0% |
| EPS (Diluted) | -$0.18 | -280.0% |
| Stockholders' Equity |
| -$4.0M |
| +68.5% |